Gareth Kristensen’s practice focuses on intellectual property, technology, and commercial contracts matters, particularly in the life sciences, financial services, and technology sectors.

Gareth advises leading multinational corporations, private equity firms, and high-growth companies on the IP, technology, and commercial contracts aspects of M&A, joint ventures and collaborations, complex carve-outs and business separations, capital markets offerings, and other significant corporate and commercial transactions.

His commercial contracts experience includes collaboration, option, and licence agreements; manufacturing, supply, and distribution agreements; transitional services and IT infrastructure separation agreements; co-marketing and co-promotion agreements; consortium agreements; R&D services arrangements; IT outsourcings; business and digital transformation projects; and e-commerce arrangements.

Gareth’s practice covers the full range of IP rights, including patents, trademarks, copyright, design rights, database rights, and trade secrets, and he has extensive experience of structuring and negotiating patent, trademark, software, and data licenses across all sectors.

He also advises on the full range of legal issues relating to data, including data protection (GDPR), privacy, and cybersecurity matters.

Gareth joined the firm in 2011. He was resident in the New York office in 2018, and he has previously been on secondment in London to GlaxoSmithKline’s IP licensing and transactions team.

Notable Experience: Intellectual Property Transactions

Pharma/Life Sciences

  • Wockhardt, the global pharmaceutical and biotechnology major, in its agreement with AstraZeneca for the manufacture and supply of the fill-finished Oxford/AstraZeneca COVID-19 vaccine for the United Kingdom; and in its agreement with the UK government (BEIS) to manufacture and supply various COVID-19 vaccines for the United Kingdom.

  • GlaxoSmithKline and its group companies on numerous corporate and commercial transactions, including complex collaborations, IP licensing transactions, material transfer agreements, supply and distribution agreements, product manufacturing arrangements, and EU consortium arrangements.

  • Various South American governments and their ministries of health on their nations’ COVID-19 vaccine supply agreements with the major COVID-19 vaccine suppliers.

  • A leading global vaccines group on its agreement to manufacture and supply drug substance for one of the leading COVID-19 vaccines.

  • LivaNova PLC in the sale of its heart valve business to Gyrus Capital.

  • A leading private equity firm on several confidential biotechnology and life sciences investments.

See More

Technology, Media, and Telecoms

  • Alphabet and Google on several corporate and commercial transactions, including Google’s acquisition of Fossil’s smartwatch technology, and other joint ventures, licence, and collaboration agreements for the development of frontier technologies.

  • Schibsted, the majority shareholder of Adevinta, in Adevinta’s $9.2 billion acquisition of eBay Classifieds.

  • The Raine Group and Temasek in connection with a co-investment in SoundCloud.

  • Warburg Pincus and other investors in connection with the $1.25 billion investment in Airtel Africa Ltd.

  • The International Olympics Committee on various matters.

  • Technology licenses, branding, and commercialization agreements relating to a “hyperloop” technology development company.

  • A leading vehicle telematics technology company on data licensing matters.

  • The underwriters in concurrent SEC-registered offerings by Veoneer Inc. of $420 million of common shares and $207 million of convertible senior notes.

  • A leading online resource-sharing marketplace on e-commerce, hosting, IP licensing, platform structure, website terms, and conditions.

See More

Financial Institutions

  • Euronext in its €4.325 billion acquisition of Borsa Italiana from the London Stock Exchange Group.

  • Amundi in its €3.55 billion acquisition of Pioneer Investment from UniCredit.

  • Credit Suisse Asset Management on software, data, and other IP aspects of the spin-out of its $1 billion quantitative and systematic hedge fund.

  • Barclays Bank PLC in its sale of its global index, benchmarking, and risk analytics business to Bloomberg L.P.

  • BNP Paribas in connection with a novel transaction in relation to the transfer of Deutsche Bank’s global prime brokerage and electronic equities platform.

  • A prominent bank on a significant IT business transformation project.

See More

Consumer Goods and Services

  • Brookfield in its ₹41 billion acquisition of Leela Hotels from Hotel Leelaventure.

  • Lavazza in connection with its acquisition of Mars Drinks from Mars Inc.

  • AB InBev in its joint venture with Anadolu Efes to combine their Russian and Ukrainian beer businesses.

  • Hillhouse Capital on various matters, including its acquisition of Scotch whisky producer Loch Lomond Group, and its 50/50 joint venture with Peet’s Coffee to roll out the franchise in China.

  • Sabre Holdings in its sale of to Bravofly Rumbo Group.

See More


  • Lafarge in the divestment of €6.5 billion of assets as part of its merger with Holcim.

  • A leading global chemicals and power infrastructure group on the acquisition of a significant international power generation business.

See More

Data Protection and Privacy

  • Numerous multinational corporations on group-wide and cross-border GDPR compliance matters, GDPR and cyber-incident response, and crisis management, including leading global banks, insurers and financial institutions, State-owned enterprises, asset managers, leading European price comparison websites, and prominent retailers and fashion brands.

See More

Selected Activities

  • Member, Society for Computers and Law
  • Member, Data Protection Working Group, Financial Markets Law Committee, 2018